The relationship between the level of glutathione, impairment of glucose metabolism and complications of diabetes mellitus

Pakistan Journal of Medical Sciences

Volumn 29, Issue 4, 2013, Pages

  Kalkan, Ismail Hakki ^a   Suher, Murat ^b  

^a Kirikkale State Hospital   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Complications; Diabetes mellitus; Glutathion

Indexed keywords

ALBUMIN; FRUCTOSAMINE; GLUCOSE; GLUTATHIONE; HEMOGLOBIN A1C;

ADULT; ANALYZER; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PATHOGENESIS; URINALYSIS; VISUAL SYSTEM EXAMINATION;

EID: 84879177109     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.294.2859     Document Type: Article

References (23)

1. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24-38.
2. Vanderjagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vanderjagt DL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem. 2001;34:265-270.
3. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: Implication in redox and detoxification. Clin Chim Acta. 2003;333:19-39.
4. Nuttall SL, Dunne F, Kendall MJ, Martin U. Ageindependent oxidative stress in elderly patients with noninsulin-dependent diabetes mellitus. QJM. 1999;92:33-8.
5. Opara EC, Abdel-Rahman E, Soliman S. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism. 1999;48:1414-1417.
6. Seghieri G, Di Simplicio P, Giorgio LA. Relationship between metabolic glycaemic control and platelet content of glutathione and its related enzymes in insulin-dependent diabetes mellitus. Clin Chim Acta. 2000;299:109-117.
7. Lang CA, Naryshkin S, Schneider DL, Mills BJ, Lindeman RD. Low blood glutathione concentrations in healthy aging adults. J Lab Clin Med. 1992;120:720-725.
8. Ceriello A. Giugliano D. Oxidative stress and Diabetic complications. In: Alberti KGMM, Zimmet P, Fronzo RA. International Textbook of Diabetes Mellitus. John Wiley, Chichester, UK: 2001:1453-1461.
9. Seghrouchni I, Drai J, Bannier E, Riviere J, Calmard P, Garcia I, et al. Oxidative stress parameters in type 1, type 2 and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta. 2002;321:89-96.
10. Powell LA, Nally SM, McMaster D, Catherwood MA, Trimble ER. Restoration of glutathione levels in vascular smooth muscle cells exposed to high glucose conditions. Free Radic Biol Med. 2001;31:1149-1155.
11. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19;257-267.
12. Wierusz-Wysocka B, Wysocki H, Byks H, Zozulińska D, Wykretowicz A, Kaźmierczak M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res Clin Pract. 1995;26:193-197.
13. Bambolkar S, Sainani GS: Evaluation of oxidative stress with or without vascular complications. J Assoc Physicians India. 1995;43:10-12.
14. Rema M, Mohan V, Bhaskar A, Shanmugasundaram KR. Does oxidant stress play a role in diabetic retinopathy? Indian J Ophtalmol. 1995;43:17-21. Glutathione and Diabetes Mellitus 5 Pak J Med Sci 2013 Vol. 29 No. 4 www.pjms.com.pk
15. Van Dam PS, van Asbeck BS, Erkelens DW, Marx JJM, Gispen WH, Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev. 1995;11;181-192.
16. Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. Diabetes Care. 1996;19:1225-1228.
17. Chiarelli F, Di Marzio D, Santilli F, Mohn A, Blasetti A, Cipollone F, et al. Effects of Irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy. Diabetes Care. 2005;28:1690-1697.
18. Beisswenger PJ, Drummond KS, Nelson RG, Howell SK. Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes. 2005;54:3274-3281.
19. Özdemir G, Özden M, Maral H, Kuskay S, Çetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann Clin Biochem. 2005;42:99-104.
20. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42:801-813.
21. Agardh CD, Agardh E, Qian Y, Hultberg B. Glutathione levels are reduced in diabetic rat retina but are not influenced by ischemia followed by recirculation. Metabolism. 1998;47:269.
22. Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care. 2000;23:234-240.
23. Kowluru RA, Kern TS, Engerman, Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes. 1996;45:1233-1237.